Gambaran Penggunaan Obat Bahan Alam dan Potensi Interaksinya pada Pasien Hipertensi dan Diabetes Melitus Peserta PROLANIS di Kota Yogyakarta

Authors

  • Artha Woro Utami Poltekkes Bhakti Setya Indonesia
  • Trilestari Trilestari Poltekkes Bhakti Setya Indonesia
  • Ismiyati Ismiyati Poltekkes Bhakti Setya Indonesia
  • Gita Mayasari Rumah Sakit Umum Daerah Kota Yogyakarta
  • Muhammad Senoaji Wibowo Poltekkes Bhakti Setya Indonesia
  • Restu Istya Ambari Putra Poltekkes Bhakti Setya Indonesia
  • Rygyna Selkly Prihatin Poltekkes Bhakti Setya Indonesia
  • Senlia Nur Eka Saputri Poltekkes Bhakti Setya Indonesia
  • Sherly Amelia Poltekkes Bhakti Setya Indonesia
  • Triyani Triyani Poltekkes Bhakti Setya Indonesia

DOI:

https://doi.org/10.29408/sinteza.v6i2.36112

Keywords:

complementary therapy, diabetes mellitus, herbal medicine, hypertension

Abstract

Hypertension and diabetes mellitus are the non-communicable diseases with the highest prevalence in the Special Region of Yogyakarta. The use of herbal medicines (obat bahan alam, OBA) as complementary therapy has grown among chronic disease patients, including in Program Pengelolaan Penyakit Kronis (PROLANIS) participants, yet OBA profiles and their potential drug interactions remain poorly characterized in this population. This study described OBA use profiles among hypertensive and diabetic PROLANIS participants at primary health centers in Yogyakarta City. A descriptive cross-sectional study was conducted at five primary health centers (Puskesmas) in Yogyakarta City from January to May 2025. A total of 160 respondents (hypertension n=115, diabetes mellitus n=45) were enrolled through consecutive sampling, and data were collected via structured face-to-face interviews and analyzed descriptively. Respondents were predominantly female (70.0%), aged 65 years or older (48.8%), and housewives (52.5%). In the hypertension group, the most commonly used OBAs were kunyit asam (28.7%), beras kencur (20.9%), and ginger (20.0%); in the diabetes mellitus group, kunyit asam (26.7%), turmeric (22.2%), and jahe (20.0%) predominated. Most OBAs were taken as liquid preparations (80.0%), sourced from tukang jamu (45.0%) or prepared at home (44.4%). Friends and relatives were the primary information source (68.1%), while only 3.1% of respondents received information from healthcare providers. Cross-tabulation of the 47 respondents currently using OBA revealed amlodipine combined with kunyit (turmeric) as the most frequent drug-herb combination, with pharmacokinetic interaction potential via CYP3A4 inhibition. Perceived therapeutic benefit was reported by 75.6% of respondents, and 77.5% intended to continue using OBA. OBA use is widespread among PROLANIS participants, and combinations carrying pharmacokinetic interaction risk, notably kunyit with amlodipine or angiotensin receptor blockers, and hypoglycemic OBAs with sulfonylureas and insulin, warrant systematic monitoring. Pharmacist-led OBA counselling at primary health facilities should be strengthened.

References

Ab Rahman, N. S., Abd Majid, F. A., Abd Wahid, M. E., Zainudin, A. N., Zainol, S. N., Ismail, H. F., Wong, T. S., Tiwari, N. K., Giri, S., & Bhargava, V. (2018). Evaluation of herb-drug interaction of Synacinn™ and individual biomarker through cytochrome 450 inhibition assay. Drug Metabolism Letters, 12(1), 62–67. https://doi.org/10.2174/1872312812666180314112457

Ahad, A., Raish, M., Abdelrahman, I. A., Ahmad, A., & Bin Jardan, Y. A. (2022). Changes in pharmacokinetics and pharmacodynamics of losartan in experimental diseased rats treated with Curcuma longa and Lepidium sativum. Pharmaceuticals (Basel), 16(1). https://doi.org/10.3390/ph16010033

Alqathama, A., Alluhiabi, G., Baghdadi, H., Aljahani, I., Hindi, A., Khaled, W., Alrawili, B., Alhathal, B., Alenizy, H., Alyahya, I., Alshamrani, F., Alotaibi, M., Alotaibi, A., & Mahomoodally, M. F. (2020). Herbal medicine from the perspective of type II diabetic patients and physicians. BMC Complementary Medicine and Therapies, 20(1), 65. https://doi.org/10.1186/s12906-020-2854-4

BPJS Kesehatan. (2015). Panduan Praktis Prolanis (Program Pengelolaan Penyakit Kronis). BPJS Kesehatan.

BPOM RI. (2004). Keputusan Kepala BPOM Nomor HK.00.05.4.2411 tentang Ketentuan Pokok Pengelompokan dan Penandaan Obat Bahan Alam Indonesia. BPOM RI.

Butt, M. D., Ong, S. C., Rafiq, A., Kalam, M. N., Sajjad, A., Abdullah, M., Malik, T., Yaseen, F., & Babar, Z. U. (2024). A systematic review of the economic burden of diabetes mellitus: contrasting perspectives from high and low middle-income countries. Journal of Pharmaceutical Policy and Practice, 17(1), 2322107. https://doi.org/10.1080/20523211.2024.2322107

Dewi, R. S., Illahi, S. F. N., Pratiwi, E., & Agustini, T. T. (2019). Persepsi masyarakat mengenai obat tradisional di Kelurahan Simpang Baru Kecamatan Tampan Kota Pekanbaru. Jurnal Penelitian Farmasi Indonesia, 8(2), 75–79. https://doi.org/10.51887/jpfi.v8i2.782

Dinkes Kota Yogyakarta. (2023). Penguatan Deteksi Dini Faktor Risiko Penyakit Tidak Menular (DDFR PTM) Kota Yogyakarta. https://kesehatan.jogjakota.go.id/berita/id/512/

GBD 2023 Collaborators. (2025). Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, 1990–2023. Lancet, 406(10513), 1873–1922. https://doi.org/10.1016/S0140-6736(25)01637-X

Hamzah, D. F. (2019). Analisis penggunaan obat herbal pasien diabetes mellitus tipe II di Kota Langsa. Jurnal JUMANTIK, 4(2), 168–177.

Hanifa, A., Febriani, Y., & Gemantari, B. M. (2024). Analisis kandungan piroksikam dan deksametason pada jamu pegal linu yang beredar di Lombok Timur. Sinteza, 4(1), 8–22. https://doi.org/10.29408/sinteza.v4i1.17436

Hendrayana, T., Yoana, K., Adnyana, I. K., & Sukandar, E. Y. (2023). Cucumber (Cucumis sativus L.) fruit and combination with losartan attenuate the elevation of blood pressure in hypertensive rats induced by angiotensin II. Journal of Pharmacopuncture, 26(4), 298–306. https://doi.org/10.3831/KPI.2023.26.4.298

Kemenkes RI. (2016). Peraturan Menteri Kesehatan Republik Indonesia Nomor 6 Tahun 2016 tentang Formularium Obat Herbal Asli Indonesia. Kemenkes RI.

Kemenkes RI. (2021). Konsumsi jamu jadi upaya promotif preventif, ini manfaatnya. https://sehatnegeriku.kemkes.go.id/baca/rilis-media/20210527/4737841/

Kemenkes RI. (2024). Survei Kesehatan Indonesia (SKI) 2023 Dalam Angka. Badan Kebijakan Pembangunan Kesehatan.

Kazi, D. S., Elkind, M. S. V., Deutsch, A., Dowd, W. N., Heidenreich, P., Khavjou, O., Mark, D., Mussolino, M. E., Ovbiagele, B., Patel, S. S., Poudel, R., Weittenhiller, B., Powell-Wiley, T. M., & Joynt Maddox, K. E. (2024). Forecasting the economic burden of cardiovascular disease and stroke in the United States through 2050: A presidential advisory from the American Heart Association. Circulation, 150(2), e89–e101. https://doi.org/10.1161/CIR.0000000000001258

Kyu, H. H., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., & GBD 2017 DALYs and HALE Collaborators. (2018). Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet, 392(10159), 1859–1922. https://doi.org/10.1016/S0140-6736(18)32335-3

Li, K.-X., Wang, Z.-C., Machuki, J. O., Li, M.-Z., Wu, Y.-J., Niu, M.-K., Yu, K.-Y., Lu, Q.-B., & Sun, H.-J. (2022). Benefits of curcumin in the vasculature: A therapeutic candidate for vascular remodeling in arterial hypertension and pulmonary arterial hypertension? Frontiers in Physiology, 13, 848867. https://doi.org/10.3389/fphys.2022.848867

Lin, S. S., Tsai, C. L., Tu, C. Y., & Hsieh, C. L. (2015). Reducing drug-herb interaction risk with a computerized reminder system. Therapeutics and Clinical Risk Management, 11, 247–253. https://doi.org/10.2147/TCRM.S78124

Muthukuda, C., Jayaratne, N., Perera, P., Perera, B., Jayawardena, R., & Ranasinghe, P. (2025). Effects of Cinnamomum zeylanicum extract on lipid profile, glucose levels and its safety in adults: A randomized, double-blind, controlled trial. PLoS One. https://doi.org/10.1371/journal.pone.0317904

Paramita, S., Isnuwardana, R., Nuryanto, M. K., Djalung, R., Rachmawatiningtyas, D. G., & Jayastri, P. (2017). Pola penggunaan obat bahan alam sebagai terapi komplementer pada pasien hipertensi di Puskesmas. Jurnal Sains dan Kesehatan, 1(7), 367–376. https://doi.org/10.25026/jsk.v1i7.56

Presiden Republik Indonesia. (2023). Undang-Undang Republik Indonesia Nomor 17 Tahun 2023 tentang Kesehatan. Republik Indonesia.

Rahayu, Y. Y. S., Araki, T., & Rosleine, D. (2020). Factors affecting the use of herbal medicines in the universal health coverage system in Indonesia. Journal of Ethnopharmacology, 260, 112974. https://doi.org/10.1016/j.jep.2020.112974

Rahmawati, R., & Bajorek, B. (2018). The use of traditional medicines to lower blood pressure: A survey in rural areas in Yogyakarta. Australasian Medical Journal, 11(3), 153–162. https://doi.org/10.21767/AMJ.2018.3269

Retta, E., Kusumajaya, H., & Arjuna, A. (2023). Faktor-faktor yang berhubungan dengan pemilihan pengobatan herbal pada pasien diabetes mellitus. Jurnal Penelitian Perawat Profesional, 5(4), 1541–1552. https://doi.org/10.37287/jppp.v5i4.1891

Shengule, S., Kumbhare, K., Patil, D., Mishra, S., Apte, K., & Patwardhan, B. (2018). Herb-drug interaction of Nisha Amalaki and Curcuminoids with metformin in normal and diabetic condition: A disease system approach. Biomedicine & Pharmacotherapy, 101, 591–598. https://doi.org/10.1016/j.biopha.2018.02.032

Tulunay, M., Aypak, C., Yikilkan, H., & Gorpelioglu, S. (2015). Herbal medicine use among patients with chronic diseases. Journal of Intercultural Ethnopharmacology, 4(3), 217–220. https://doi.org/10.5455/jice.20150623090040

Utami, A. W., Wijyanti, A., & Novarina, D. (2021). Penggunaan obat tradisional pada pasien hipertensi di Puskesmas Gondokusuman I. Jurnal Ilmu Kesehatan Bhakti Setya Medika, 6(2), 100–107.

Utami, P. R., Pratiwi, E. D., & Tiyas, D. S. A. (2026). Pengaruh faktor risiko terhadap efek samping hipotensi ortostatik pada pasien hipertensi dengan komorbid diabetes mellitus. Sinteza, 6(1), 17–28. https://doi.org/10.29408/sinteza.v6i1.31990

Utomo, A. W., Annisaa, E., Antari, A. L., & Armalina, D. (2022). The use of herbal medicines in patients with type-2 diabetes mellitus in Indonesia. Sains Medika, 13(1), 12–17. https://doi.org/10.30659/sainsmed.v13i1.13487

Vatsavai, L. K., & Kilari, E. K. (2016). Influence of curcumin on the pharmacodynamics and pharmacokinetics of gliclazide in animal models. Journal of Experimental Pharmacology, 8, 69–76. https://doi.org/10.2147/JEP.S117042

Verma, N., Singh, A. K., & Mishra, G. (2021). Plants used as antihypertensive. Natural Products and Bioprospecting, 11, 1–25. https://doi.org/10.1007/s13659-020-00281-x

Vinata, C. E. (2021). Persepsi penderita hipertensi terhadap penggunaan obat herbal dalam terapi komplementer hipertensi di Kota Denpasar. Bali International Scientific Forum, 2(1), 1–16. https://doi.org/10.34063/bisf.v2i1.279

Widayati, A., Hadning, I., & Wulandari, E. T. (2025). Factors associated with herbal usage among hypertensive and diabetic patients in Yogyakarta, Indonesia: A cross-sectional study. Scientific Reports, 16(1), 2218. https://doi.org/10.1038/s41598-025-31978-z

Widjajakusuma, E. C., Jonosewojo, A., Hendriati, L., Wijaya, S., Ferawati, Surjadhana, A., Sastrowardoyo, W., Monita, N., Muna, N. M., Fajarwati, R. P., Ervina, M., Esar, S. Y., Soegianto, L., Lang, T., & Heriyanti, C. (2018). Phytochemical screening and preliminary clinical trials of the aqueous extract mixture of Andrographis paniculata (Burm. f.) Wall. ex Nees and Syzygium polyanthum (Wight.) Walp leaves in metformin treated patients with type 2 diabetes. Phytomedicine, 55, 137–147. https://doi.org/10.1016/j.phymed.2018.07.002

Widyawati, T., Yusoff, N. A., Bello, I., Asmawi, M. Z., & Ahmad, M. (2022). Bioactivity-guided fractionation and identification of antidiabetic compound of Syzygium polyanthum leaf extract. Molecules, 27(20), 6814. https://doi.org/10.3390/molecules27206814

Yaribeygi, H., Sathyapalan, T., Jamialahmadi, T., & Sahebkar, A. (2021). Natural insulin sensitizers for the management of diabetes mellitus. Advances in Experimental Medicine and Biology, 1328, 401–410. https://doi.org/10.1007/978-3-030-73234-9_26

Downloads

Published

2026-08-08

How to Cite

Utami, A. W., Trilestari, T., Ismiyati, I., Mayasari, G., Wibowo, M. S., Putra, R. I. A., … Triyani, T. (2026). Gambaran Penggunaan Obat Bahan Alam dan Potensi Interaksinya pada Pasien Hipertensi dan Diabetes Melitus Peserta PROLANIS di Kota Yogyakarta. Sinteza, 6(2), 132–149. https://doi.org/10.29408/sinteza.v6i2.36112

Issue

Vol. 6 No. 2 (2026): August

Section

Articles

License

Copyright (c) 2026 Sinteza

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish in Sinteza, agree to retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License (CC-BY License). This license allows authors to use all articles, data sets, graphics, and appendices in data mining applications, search engines, web sites, blogs, and other platforms by providing an appropriate reference. The journal allows the author(s) to hold the copyright without restrictions and will retain publishing rights without restrictions.